Physician profile

Mark W Dersch

Urology · Ocala, FL

NPI 1538119151

$20,663.87

in general payments reported to CMS, 2019-2025

58 companies · $2,204 in 2025

The $2,204 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,797.23
Education$252.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Laser Specialty Medical, LLC $9,500.00 2019-2021
Astellas Pharma US INC $1,209.88 2019-2025 Xtandi, Myrbetriq
Myriad Genetic Laboratories, INC. $1,101.16 2021-2025 Prolaris
Bayer Healthcare Pharmaceuticals INC. $930.32 2019-2025
Janssen Biotech, INC. $890.97 2019-2025 Erleada, Akeega
Sumitomo Pharma America, INC. $655.57 2023-2025 Gemtesa, Orgovyx
Teleflex LLC $545.71 2021-2025 Urolift, Barrigel, Solesta
Coloplast Corp $542.19 2019-2023 Porges Coloplast
Abbvie INC. $343.09 2019-2025 Lupron Depot, Botox
Procept Biorobotics Corporation $337.63 2019-2025 Aquabeam System
Astrazeneca Pharmaceuticals LP $319.54 2020-2023 Lynparza
Urovant Sciences INC $315.01 2021-2022
180 Medical, INC. $288.55 2019-2022
Myovant Sciences INC. $254.23 2021-2022
Urogen Pharma, INC. $250.78 2020-2025 Jelmyto
Show all 56 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $248.01 2019-2025
Dendreon Pharmaceuticals LLC $218.60 2019-2025 Provenge
Axonics, INC. $200.83 2020-2024 Axonics
Ferring Pharmaceuticals INC. $179.43 2024-2025 Adstiladrin
Telix Pharmaceuticals $172.20 2022-2025 Illuccix
Tolmar Pharmaceuticals, INC. $148.09 2019-2022
Allergan, INC. $144.67 2019-2022
Endo Pharmaceuticals INC. $121.19 2019-2024 Xiaflex, Aveed
Novartis Pharmaceuticals Corporation $117.62 2022-2025
Medtronic, INC. $110.20 2024 Nuro
Merck Sharp & Dohme LLC $110.02 2022-2024 Keytruda, Lynparza
Accord Healthcare, INC. $103.20 2022-2025
Angiodynamics, INC. $102.80 2025 Nanoknife
Antares Pharma, INC. $100.55 2019-2022
Tolmar, INC. $99.33 2023
Blue Earth Diagnostics $95.54 2020-2025 Posluma
Dentsply Ih INC. $95.49 2019-2021
Foundation Medicine, INC. $90.50 2020-2023
Seagen INC. $84.99 2025
Caldera Medical, INC $77.54 2023 Desara
Boston Scientific Corporation $74.67 2019-2025 Spaceoar Vue System - 10ml
Rochester Medical Corporation $58.47 2019-2020
Immunitybio, INC. $44.63 2025
Olympus America INC. $40.72 2023-2024 Itind System
Verity Pharmaceuticals INC. $32.30 2023 Trelstar
Endo USA, INC. $29.15 2025 Xiaflex
Baxter Healthcare $25.75 2021
Progenics Pharmaceuticals, INC. $24.92 2025
Sun Pharmaceutical Industries INC. $24.89 2020
Alnylam Pharmaceuticals INC. $24.17 2021
Neotract INC. $22.81 2019
Baudax Bio INC. $18.99 2021
Laborie Medical Technologies Corp. $18.58 2024 Optilume Bph Drug Coated Balloon Catheter
Becton, Dickinson and Company $18.44 2025 Bard Urinary Drainage Bag
Amgen INC. $17.62 2020
Dentsply Ih Ab $16.09 2023 Lofric
Travere Therapeutics, INC. $15.76 2020
Bioprotect Medical, INC. $13.54 2024 Bioprotect Balloon Implant System
Metuchen Pharmaceuticals $12.89 2019
Cook Medical LLC $12.48 2019
Acerus Pharmaceuticals Corporation $11.57 2020

2 companies reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$136,647.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Mark W Dersch

$20,663.87

in general payments reported 2019-2025

Years
2019-2025
Top company
Laser Specialty Medical, LLC
Context
The $2,204 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/160681/mark-w-dersch

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.